Charles River Will Buy WuXi PharmTech

Charles River Laboratories has agreed to buy WuXi PharmTech, in a deal that Bloomberg News calls the "largest foreign takeover of a Chinese company" to date. The move eliminates a potential competitor for Charles River and gives it an instant major presence in the Chinese contract research and manufacturing market. For the full story, click here.

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments